Your browser doesn't support javascript.
loading
"Chagas Express XXI": A new ArtScience social technology for health and science education-A case study in Brazilian endemic areas of Chagas disease with an active search of chronic cases.
Araujo-Jorge, Tania C; Ferreira, Roberto R; Rocha, Rita C M; Vieira, Thallyta M; Costa, Nancy D; Santos, Luzia L; Silva, Josefa O; Mendes, Marcelo O; Almeida-Silva, Juliana; Costa, Erik J; Mexas, Rodrigo; Oliveira, Jonathan G; Suarez-Fontes, Ana M; Gonçalves, Teresa C M; Lopes, Catarina M; Mello, Marcio L; Borges, Cristina X A; Garzoni, Luciana R; Gibaldi, Daniel; Lannes-Vieira, Joseli; Vannier-Santos, Marcos A.
Afiliação
  • Araujo-Jorge TC; Laboratory of Innovations in Therapies, Education and Bioproducts, Oswaldo Cruz Institute (LITEB-IOC/Fiocruz), Oswaldo Cruz Foundation (Fiocruz), Rio de Janeiro Brazil.
  • Ferreira RR; Laboratory of Innovations in Therapies, Education and Bioproducts, Oswaldo Cruz Institute (LITEB-IOC/Fiocruz), Oswaldo Cruz Foundation (Fiocruz), Rio de Janeiro Brazil.
  • Rocha RCM; Laboratory of Functional Genomics and Bioinformatics, Oswaldo Cruz Institute (LAGFB-IOC/Fiocruz), Oswaldo Cruz Foundation (Fiocruz), Rio de Janeiro, Brazil.
  • Vieira TM; Laboratory of Innovations in Therapies, Education and Bioproducts, Oswaldo Cruz Institute (LITEB-IOC/Fiocruz), Oswaldo Cruz Foundation (Fiocruz), Rio de Janeiro Brazil.
  • Costa ND; Center for Biological and Health Science, Universidade Estadual de Montes Claros, Minas Gerais, Brazil.
  • Santos LL; Rio Chagas Association, Rio de Janeiro, Brazil.
  • Silva JO; Rio Chagas Association, Rio de Janeiro, Brazil.
  • Mendes MO; Rio Chagas Association, Rio de Janeiro, Brazil.
  • Almeida-Silva J; Laboratory of Innovations in Therapies, Education and Bioproducts, Oswaldo Cruz Institute (LITEB-IOC/Fiocruz), Oswaldo Cruz Foundation (Fiocruz), Rio de Janeiro Brazil.
  • Costa EJ; Laboratory of Innovations in Therapies, Education and Bioproducts, Oswaldo Cruz Institute (LITEB-IOC/Fiocruz), Oswaldo Cruz Foundation (Fiocruz), Rio de Janeiro Brazil.
  • Mexas R; Laboratory of Innovations in Therapies, Education and Bioproducts, Oswaldo Cruz Institute (LITEB-IOC/Fiocruz), Oswaldo Cruz Foundation (Fiocruz), Rio de Janeiro Brazil.
  • Oliveira JG; Institute for Science and Technology Information, (ICICT/Fiocruz), Oswaldo Cruz Foundation, Rio de Janeiro, Brazil.
  • Suarez-Fontes AM; Laboratory of Biology and Parasitology of Wild Reservoir Mammals, Oswaldo Cruz Institute (LABPMR-IOC/Fiocruz), Oswaldo Cruz Foundation, Rio de Janeiro, Brazil.
  • Gonçalves TCM; Laboratory of Innovations in Therapies, Education and Bioproducts, Oswaldo Cruz Institute (LITEB-IOC/Fiocruz), Oswaldo Cruz Foundation (Fiocruz), Rio de Janeiro Brazil.
  • Lopes CM; Interdisciplinary Laboratory in Entomological surveillance in Diptera and Hemiptera, Oswaldo Cruz Institute (LIVEDIH-IOC/Fiocruz), Oswaldo Cruz Foundation, Rio de Janeiro, Rio de Janeiro, Brazil.
  • Mello ML; Interdisciplinary Laboratory in Entomological surveillance in Diptera and Hemiptera, Oswaldo Cruz Institute (LIVEDIH-IOC/Fiocruz), Oswaldo Cruz Foundation, Rio de Janeiro, Rio de Janeiro, Brazil.
  • Borges CXA; Laboratory of Innovations in Therapies, Education and Bioproducts, Oswaldo Cruz Institute (LITEB-IOC/Fiocruz), Oswaldo Cruz Foundation (Fiocruz), Rio de Janeiro Brazil.
  • Garzoni LR; Laboratory of Innovations in Therapies, Education and Bioproducts, Oswaldo Cruz Institute (LITEB-IOC/Fiocruz), Oswaldo Cruz Foundation (Fiocruz), Rio de Janeiro Brazil.
  • Gibaldi D; Laboratory of Innovations in Therapies, Education and Bioproducts, Oswaldo Cruz Institute (LITEB-IOC/Fiocruz), Oswaldo Cruz Foundation (Fiocruz), Rio de Janeiro Brazil.
  • Lannes-Vieira J; Vice-Presidency of Environment, Healthcare and Health Promotion (VPAAPS/Fiocruz), Oswaldo Cruz Foundation, Rio de Janeiro, Brazil.
  • Vannier-Santos MA; Laboratory of Biology of the Interactions, Oswaldo Cruz Institute (LBI-IOC/Fiocruz), Oswaldo Cruz Foundation, Rio de Janeiro, Brazil.
PLoS Negl Trop Dis ; 15(7): e0009534, 2021 07.
Article em En | MEDLINE | ID: mdl-34288905
ABSTRACT

BACKGROUND:

Chagas Disease (CD) affects 6-7 million people worldwide and is related to poverty-promoting conditions. Chronic asymptomatic cases are mostly invisible to health systems. Aiming (1) to translate CD discoveries into education/information practices to raise alertness and empowerment of affected people; and (2) to perform an active search of CD cases, articulating intersectoral actions to improve the access of infected people to the local health service for the treatment of CD; our research group developed and tested under field conditions as innovative social technology an itinerant education interdisciplinary setting named "Chagas Express XXI" (CE21).

METHODOLOGY:

CE21 was created as an "imaginary train" with ~40 ArtScience workshops, games, laboratory activities and conversation circles. An entry/exit plus six activity modules combined associations of affected people, microscopic observations, One Health education, and wellness activities. CE21 was conceived as a social technology, since all the processes were co-created with CD patients and inter-sector local partners. Descriptive statistics showed quantitative data collected throughout the expeditions (CD knowledge, serological results). Qualitative data accessed the public perceptions about the education activities. PRINCIPAL

FINDINGS:

CE21 was exhibited in local educational institutions (schools, universities) in four cities, engaging 2,117 people that evaluated the 41 activities carried out. Citizens and health professionals enjoyed acquisition of information related to blood, parasites, vectors, reservoirs, environmental changes, and social determinants of CD. Further, local legacies of 600 participants volunteer for health promotion groups and CD associations, local empowerment groups to fight for better health conditions, and 05 mural paintings. We observed that 81% of the participants ignored the possibility of treating CD while 52% of the participants requested a blood test for CD showing seropositivity in 20% of them.

CONCLUSIONS:

CE21 is a social technology potentially useful for health and science education and active search of asymptomatic CD chronic cases. Moreover, this technology may be adapted to understand and to cooperate in other potentially epidemic situations, especially NTDs related.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Ciência / Educação em Saúde / Doença de Chagas / Promoção da Saúde Tipo de estudo: Qualitative_research Limite: Adult / Aged / Female / Humans / Male / Middle aged País/Região como assunto: America do sul / Brasil Idioma: En Revista: PLoS Negl Trop Dis Assunto da revista: MEDICINA TROPICAL Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Ciência / Educação em Saúde / Doença de Chagas / Promoção da Saúde Tipo de estudo: Qualitative_research Limite: Adult / Aged / Female / Humans / Male / Middle aged País/Região como assunto: America do sul / Brasil Idioma: En Revista: PLoS Negl Trop Dis Assunto da revista: MEDICINA TROPICAL Ano de publicação: 2021 Tipo de documento: Article